NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Prescription·Evidence index

Medroxyprogesterone and Vitamin D3: what the published research says

PubMed indexes 3 records that name Medroxyprogesterone and Vitamin D3 together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Medroxyprogesterone and Vitamin D3. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

3 studies naming Medroxyprogesterone and Vitamin D3.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

Women's Health Initiative clinical trials: potential interactive effect of calcium and vitamin D supplementation with hormonal therapy on cardiovascular disease.

Menopause (New York, N.Y.) · 2019 · PMID 31145202

Multicenter StudyRandomized Controlled TrialResearch Support, N.I.H., Extramural

“CaD did not consistently modify the effect of CEE therapy or CEE + MPA therapy on CVD events. However, the increased risk of stroke due to CEE therapy appears to be mitigated by CaD supplementation. In contrast, CaD supplementation did not influence the risk of stroke due to CEE + MPA.”

Jiang et al. · Authors' conclusion

Names Medroxyprogesterone and Vitamin D3 together in an interaction, co-administration, or pharmacokinetic context.

Women's Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapy.

Menopause (New York, N.Y.) · 2014 · PMID 23799356

Randomized Controlled TrialResearch Support, N.I.H., Extramural

“Postmenopausal women at normal risk for hip fracture who are on CaD supplementation experience significantly reduced incident hip fractures beyond HT alone at all levels of personal baseline total calcium intake.”

Robbins et al. · Authors' conclusion

Names Medroxyprogesterone and Vitamin D3 together in an interaction, co-administration, or pharmacokinetic context.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Medroxyprogesterone, Vitamin D3, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.